Search
Boundless Bio Inc
BOLDAdd to Watchlist
2.410USD
0.0000.00%
Close 10-27 16:00（ET）
54.83MMarket Cap
LossP/E TTM
BOLD Analyst Recommendation Trends
In the current month, BOLD has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. BOLD average Analyst price target in the last month is 4.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
2
2
2
2
2
Financial Forecasting
Based on analysts' estimates, BOLD EPS is projected to reach -0.560 in FY2026Q3, following reported EPS of -1.055 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.52
-0.58
-0.58
-0.56
-0.32
Actual
-0.58
-0.60
-1.06
--
--
Surprise
-10.63%
-4.90%
-81.96%
--
--
FAQs
How have Boundless Bio IncBOLD's recent earnings per share performed?
The market expectation was USD -1.06, while Boundless Bio IncBOLD's earnings per share (EPS) for the previous quarter was USD -0.60. EPS for the next quarter is expected at USD -0.56.
What is the analyst rating for Boundless Bio Inc?
Based on the ratings of Boundless Bio Inc's stock from 1 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.